For 25 years, Ivan Brandslund has been a laboratory director and chief physician at Vejle Hospital and at the same time held a lecturer in teaching and research at the Faculty of Health Sciences, University of Southern Denmark (SDU). He is the author of over 150 scientific articles on the development and application of methods for rational diagnostics and control of human disease treatment. In recent years, especially in blood thinning treatment, cancer and diabetes. Ivan Brandslund is a specialist in clinical biochemistry at OUH and holds a scientific career from SDU and as an international research fellow at Dept. Of Public Health, USA, from which he was taken to the Laboratory at Vejle Hospital in 1985. He was the main character behind the building of the Laboratory Center at Vejle Hospital, which houses five medical diagnostic specialties, with a large and growing scientific production. His future research efforts will focus on biochemical nanotechnology methods that will enable measurement of single cell protein, RNA and DNA for diagnostic and individual treatment management in cancer and diabetes based on the isolation of cancer cells in a blood sample and on blood indicator proteins, in collaboration with oncologists And diabetes doctors in the Region of Southern Denmark. Ivan Brandslund is a partner in the National Diabetes Type 2 project, DD2, with analysis / biobank functions, and groups in cancer research, among others. The Danish National Board of Health on a new method for screening for cervical cancer.

.

Dr. Swenberg’s long, successful research career focused on chemical carcinogenesis and toxicology, with an emphasis on studying the role of DNA damage and repair in carcinogenesis, developing highly sensitive assay methods for DNA and protein adduct research and improving the scientific basis of risk assessment. He makes extensive use of mass spectroscopy for biomarker studies. After a successful industrial and research institute career, he joined UNC-Chapel Hill as a professor in the Department of Environmental Sciences and Engineering. In addition to his Department of Nutrition appointment, he is also a professor in the Department of Pathology and Laboratory Medicine and is the Director of Curriculum in Toxicology. He is affiliated with the Department of Nutrition as a trainer on the Department of Nutrition’s NIH Training Grant. His work on oxidant damage is of great interest to the Department and he contributes research supervision and instruction to Nutrition graduate students. He is a member of numerous prestigious toxicology and pathology societies and serves on several science and editorial advisory boards.

Chemical carcinogenesis and toxicology, Role of DNA damage and repair in carcinogenesis, Development of highly sensitive assay methods for DNA and protein adduct research

Roberto Menicagli has completed his Ph.D. at the age of 25 years from Milan University. Postdoctoral studies in biochemistry and molecular genetics, the faculty of biology at Milan University. In this university, he has been professor to Contract, and became responsible for the Project ENEA-CNR for Environmental Pollution and Biomarkers ,after thirty years ,in industrial biochemistry experience ,as Senior Research in ENIRESEARCH, the most important group of the research in Italy, now, for five years, he is the director of Roma Biomed Research Lab a Private Medical Service Organization. He has published, in this field, more than 20 papers, in many journals, some with Impact Factor, he is also the principal author of 4 international patents, in the field of the environment and biomarkers, and has been serving as an editorial board member of some magazines, concerning the medical sciences.

Medicinal Chemistry, industrial biochemistry, biochemistry and molecular genetics

Dr. Claudio Sorio is Associate Professor of General Pathology. He is the founder and serves as Director of the Departmental Laboratory of Translational Research In Cystic Fibrosis of the Department of Medicine of the University of Verona. Study of Biomarkers for Cancer and Cystic Fibrosis are the main field of interests, with a specific focus on the role of Protein Tyrosine Phosphatase Gamma (PTPRG) in health and disease, that he discoverd having a role as dendritic cell biomarker and as tumor suppressor gene in chronic myeloid leukemia. In the field of cystic fibrosis since 2009 he promoted the study of the role of leukocytes, especially monocytes, in the disease and as a tool to better understand its pathogenesis and be exploited as disease biomarker. He has been leading and actively participating to multiple research projects in leukemia and Cystic Fibrosis. He authored 74 original publications in international journals and is the single major contributor in the field of PTPRG characterization. He has been serving as an editorial board member of various reputed journals. He is member of many scientific societies and has participated in relevant national and international research projects.

Biomarkers of disease

Dr. Nickolas is an anatomic pathologist with interest in breast surgical pathology. In addition he is interested in evidence-based medicine in respect to efficiency of medical interventions and accuracy of diagnostic procedures.Currently he is a Clinical Associate Professor at UBC and Anatomical Pathologist at St.Paul’s Hospital. He is awarded with UICC Fellowship for junior investigators, 2007-2008, Government of Newfoundland and Labrador, Travelling Fellowship, 2007-2008, and Canadian Association of Pathologists, Junior Scientist Award, 2006. He has experience teaching a wide spectrum of topics in pathology in university settings for small and large classes, residency training, medical and non-medical students, graduate, postgraduate and undergraduate levels. He has published more than 50 research papers.

Diagnostic Surgical pathology of breast disease, evidence-based practice of pathology. I am interested in clinical research evidence synthesis through critical appraisal of medical literature; diagnostic theory based on Bayesian reasoning and nature and sources of bias in clinical research.

Assoc. Prof. Přemysl Mladěnka, Pharm.D., Ph.D. was graduated in 2003 at the Faculty of Pharmacy, Charles University, Czech Republic. He received his Ph.D. from Pharmacology and toxicology at the same institution in 2008. From 2014 he is the Associate Professor in Human and veterinary pharmacology. Currently he is also the ERASMUS+ coordinator of the Faculty of pharmacy, Charles University. Scientifically he is the head of the group of Cardiovascular and respiratory pharmacology and toxicology. At the moment, he is the author or co-author of 38 scientific papers, 36 of them in journal with IF (average IF 2.8). During his career he was awarded by several awards (e.g. in 2009 The price of the Minister of Education, Youth and Sports for remarkable results during doctoral study, 2011 The young scientist award of Danone institution for the best work in the field of nutrition, 2014 selected for the participation in the 64th Lindau Nobel Laureate Meeting, 2014 poster award for extraordinary scientific achievements at annual meeting of The Society for Free Radical Research – Europe). The full CV and the complete list of publication are available at http://portal.faf.cuni.cz/Profile/Mladenka-Premysl/?lang=en-GB.

Cardiovascular pharmacology in particular with emphasis on platelet-aggregation, cardiac function and arterial blood pressure; transition metals (iron, copper), polyphenolic compounds (flavonoids, coumarins, phenolic acids)

Dr. Omyma A. Abd-Allah is a Professor of Organic Chemistry in Department of Chemistry, Faculty of Science, Sohag University, Egypt since 2017.She awarded her M.Sc. in Organic Chemistry (1989) from Assiut University. She awarded her Ph.D. in Organic Chemistry (1995) from South Valley University. She has published more than 40 research papers in the areas of Organometallic Chemistry, Medicinal Chemistry and Organic Chemistry. She contributed in many international conferences, seminars and symposiums. Also, She has a history of several years of teaching for college students and various disciplines and trends in different universities.

Organic Chemistry, Medicinal chemistry and Organometallic Chemistry

Dr. Lopez-Ruiz has completed his Ph.D. from Valencia University and postdoctoral studies from CEU Cardinal Herrera Health Sciences Faculty. She obtained her doctorate in Medicine with the doctoral thesis on “Analysis of the use of medication in the paediatric population that visit accident and emergency department” with summa cum laude. She has achieved the qualification of “University Expert in Neonatology” from the Catholic University of Valencia and “Master’s Degree in Neonatology (from de SENeo -Neonatology Spanish Society-)”. She is Medicine Degree Coordinator in CEU Cardenal Herrera University since 2015. She is the director of the “Master’s degree in Neonatal Intensive care and Neonatal Nursing”. She has attended to International Congresses of Pediatrics as a keynote speaker and she has been part of the Organizing Committee member for the 12th International Conference on Pediatric Pathology and Laboratory Medicine, and she has published in reputed international journals.

Pediatrics, Neonatology, Human Anatomy, Pharmacology

Idress Hamad Attitalla is working as Visiting Scientist in Department of Biological Sciences, Universiti Sains Malaysia, Palau Pinang, Malaysia since 2010. In 1998, he was appointed as Lecturer Assistant at the Department of Biological Sciences, Faculty of Science, Omar Al-Mukhtar University, El-Beida, Libya. In 2004, he was appointed as Lecturer at the Department of Biological Sciences, Faculty of Science, Omar Al-Mukhtar University, El-Beida, Libya. In 2007, he was appointed as Assistant Professor at the Department of Biological Sciences, Faculty of Science, Omar Al-Mukhtar University, El-Beida, Libya. In 2009, he was appointed as Associate Professor at the Department of Biological Sciences, Faculty of Science, Omar Al-Mukhtar University, El-Beida, Libya. In 2010, he was appointed as Visiting Scientist at the Department of Biological Sciences, Universiti Sains Malaysia, Palau Pinang, Malaysia. Idress Hamad Attitalla received his B.Sc. in Biology in 1992 at Department of Biological Sciences, Faculty of Science, Omar Al-Mukhtar University, El-Beida, Libya. He got M.Sc. in Biology in 1998 from Department of Plant Pathology and Bio-control Unit, Uppsala University, Uppsala, Sweden. Dr. Idress Hamad Attitalla obtained Ph.D. from Department of Molecular Evolution, Faculty of Science and Technology, Uppsala University, Uppsala, Sweden in 2004 in Molecular Evolution.

Plant Pathology, Plant Microbiology, Molecular Evolution,Soil Sciences, Algal Physiology, Plant Immunization, Phylogenetic.

He is a Consultant Physician and Clinical Pharmacologist at National Ayurveda Teaching Hospital, Sri Lanka and Head of the Department of Ayurveda Pharmacology and Pharmaceutics Institute of Indigenous Medicine, University of Colombo, Sri Lanka. He has delivered many guest lectures and keynote speeches. Has presented and published many papers at local and international conferences and journals in areas of Pharmacology, Toxicology, Immune medicine, Traditional medicine, Ayurveda, Pharmacovigilance, Bio transformation technologies, Bio medical-clinical ethics and Medical education. Won awards for research presentations both internationally and locally for scientific publications. Received several research grants and developed a research Unit for Ayurveda products to conduct experimental studies and clinical trials in the Institute of Indigenous Medicine, University of Colombo. Supervising research of Special Degrees /Post Graduate Diploma /MSc/MD(Ayu)/MPhil/PhD readers registered at Faculty of Graduate Studies in University of Colombo, University of Sri Jayewardenepura, University of Kelaniya, University of Peradeniya, Kothalawela Defence University, Sabaragamuwa University, Institute of Chemistry and students in Institute of Indigenous Medicine, University of Colombo. Serve as a reviewer and Editorial board member of peer review International journals. Currently collaboratively conducting research works with Federation University in Australia on projects that aims to validate Mobile Phone App with Ayurveda medicine concepts (Prakriti/ Body constitution) and architecture for Ayurvedic Electronic Health Records. Held the post of Head of Department of Allied Sciences, and currently hold Head of the Department of Ayurveda Pharmacology and Pharmaceutics.

Clinical trials, Phytomedicine , Traditional medicine , Quality assurance and standardization of Pharmaceuticals, Rational use of medicines, Pharmacovigilance and Adverse drug reactions, Arthritis, Cancer, Diabetes and other immune diseases, Medical education , Bio medical-clinical ethics, Bio-transformation technologies , Intellectual Property Rights (IPRs) development

Dr. Nagham Mahmood Aljamali is an Assistant Professor in Department of Chemistry, University of Kufa, Iraq since 2011. She awarded her Ph.D. in Organic Chemistry (2008). She has published more than 50 research papers in the areas of organic chemistry, pharma, anesthesia, analytical, medical plants , plants extracted, chromatography, biological activity, organic and inorganic chemistry , complex with ions, antibiotic, and derivatives of drugs.

Organic Chemistry, Pharmaceutical Chemistry, Medicinal Plants , Analytical Chemistry, Biochemistry